Surya Narayan Patra of Phillipcapital says the news on Elepsia is more relevant to Sun Pharma. The product was linked to one of the facilities linked to USFDA issues
first published: Sep 28, 2015 11:19 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell

Live: Will Nifty's weakness continue for the second straight day? | Opening Bell

A money superpower you have in your 20s, not in 40s

Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
You are already a Moneycontrol Pro user.

